Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Tumor Progression02:07

Tumor Progression

7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RPS20 as a colorectal cancer predisposition gene: an integrated review of the literature and evaluation in 9738 cases and 161,403 controls.

Familial cancer·2026
Same author

A pan-cancer single-cell analysis of intratumoral copy number diversity and evolution.

Cancer discovery·2026
Same author

Age distinguishes selection from causation in cancer genomes.

Nature genetics·2026
Same author

Characterisation of bacteria-induced colitis and its modulation by probiotics in naked mole rats: a new mammalian model for acute inflammatory disease.

The Journal of pathology·2026
Same author

Mixed-model and transcriptome-wide association analyses identify transcription factors and genes associated with colorectal cancer susceptibility.

Nature communications·2026
Same author

Promises under pressure: the modest predictive power of polygenic risk scores.

European journal of human genetics : EJHG·2026
Same journal

Inhibiting PPM1D Perturbs Mitochondrial Integrity to Stimulate cGAS-STING Signaling and Antitumor Immunity.

Cancer research·2026
Same journal

BRD9 Degraders Unleash GBAF Chromatin Remodeling Activity in Synovial Sarcoma.

Cancer research·2026
Same journal

Virtual Tumors Enable Prediction of Personalized Therapeutic Combinations for Non-Small Cell Lung Cancer.

Cancer research·2026
Same journal

Opportunities to enhance cancer research through advocate-researcher partnerships.

Cancer research·2026
Same journal

EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma.

Cancer research·2026
Same journal

Immune checkpoint blockade augments lymphodepleting chemotherapy-induced antitumor immunity by expanding effector CD8+ T cell clones.

Cancer research·2026
See all related articles

Related Experiment Video

Updated: Jan 15, 2026

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
06:01

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

9.9K

Mathematical Modeling Quantifies "Just-Right" APC Inactivation for Colorectal Cancer Initiation.

Meritxell Brunet Guasch1, Nathalie A Feeley2, Ignacio Soriano3

  • 1School of Mathematics and the Maxwell Institute for Mathematical Sciences, University of Edinburgh, Edinburgh, United Kingdom.

Cancer Research
|October 15, 2025
PubMed
Summary
This summary is machine-generated.

Partial inactivation of the adenomatous polyposis coli (APC) gene, not complete loss, creates optimal conditions for colorectal cancer development by fine-tuning WNT signaling. This "just-right" APC inactivation level increases cancer progression probability significantly.

More Related Videos

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy
05:21

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy

Published on: October 6, 2014

10.1K
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

1.6K

Related Experiment Videos

Last Updated: Jan 15, 2026

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
06:01

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

9.9K
Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy
05:21

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy

Published on: October 6, 2014

10.1K
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

1.6K

Area of Science:

  • Oncology
  • Genetics
  • Computational Biology

Background:

  • Dysregulation of the adenomatous polyposis coli (APC) gene is crucial in colorectal cancer (CRC) development, primarily through WNT/β-catenin pathway activation.
  • Most CRCs exhibit biallelic APC mutations leading to partial, not complete, loss of function, suggesting a specific level of APC inactivation is optimal for tumorigenesis.

Purpose of the Study:

  • To develop a mathematical model to quantify the tumorigenic impact of various biallelic APC genotypes.
  • To investigate how somatic mutational processes influence APC inactivation levels and their correlation with cancer progression.

Main Methods:

  • Analysis of sequence data from over 2,500 colorectal cancer cases.
  • Development and application of a mathematical model to assess the tumorigenic effects of different APC genotypes.
  • In vivo assessment of secondary WNT driver alterations in combination with APC mutations.

Main Results:

  • APC genotypes with partial protein function were associated with a ~50-fold higher probability of cancer progression compared to complete APC inactivation.
  • The optimal APC inactivation level for tumorigenesis varied based on tumor location and the presence of additional WNT pathway mutations.
  • Mutations in AMER1 were found to enhance WNT activity in tumors with suboptimal APC genotypes.

Conclusions:

  • A "just-right" level of APC inactivation and WNT signaling appears to be a general principle in colorectal cancer development across different subtypes.
  • WNT hyperactivation, driven by specific APC inactivation levels and secondary mutations, represents a potential therapeutic vulnerability in colorectal cancer.